Antidiabetic Effects of Curcuma longa, Zingiber officinale, and Elettaria cardamomum : Scoping Review of the Family Zingiberaceae in Patients with Diabetes Mellitus
DOI:
https://doi.org/10.30595/hmj.v7i2.24364Keywords:
antidiabetic herbs, Clinical trials, Diabetes mellitus, ZingiberaceaeAbstract
Diabetes is a major problem affecting 387 million adults with a global prevalence of (8.3%) and is expected to increase to (10.1%) by 2035. The government recommends the use of herbal medicine as an effort to prevent and control diabetes mellitus. Potential herbal medicines that have antidiabetic effects are the family Zingiberaceae. Several in vitro studies on species of the Zingiberaceae showed antidiabetic activity by inhibiting the activity of the enzymes α-Amylase and α-Glucosidase. However, one problem related to the use of antidiabetic herbs from the Zingiberaceae is the lack of scientific studies showing the effects of the plants used. This scoping review aims to map clinical research evidence of the antidiabetic effects of Zingiberaceae in patients with diabetes mellitus. Using a scoping review methodology, article searches through computerized databases, namely: PubMed, Google Scholar, and Scopus, and search manually used English and Indonesian keywords. The initial search found 1239 articles, then filtered according to the inclusion and exclusion criteria such articles use the RCTs method that mentions the antidiabetic effect of Zingeberaceae family in English or Indonesian in the last 5 years (2017-2021). The results of the study showed 31 articles that met the requirements. 3 types of Zingiberaceae plants had antidiabetic effects, namely Curcuma longa (turmeric) with curcumin/nano-curcumin compounds, Elettaria cardamomum (cardamom), and Zingiber officinale (ginger) which can reduce HbA1c, fasting blood glucose, and insulin resistance in patients with diabetes mellitus with minimal side effects.
References
1. PERKENI. Pedoman pengelolaan dan pencegahan diabetes melitus Tipe 2 dewasa di Indonesia. PB PERKENI; 2019.
2. IDF. Eighth edition 2017. IDF Diabetes Atlas, 8th edition. International Diabetes Federation; 2017. 1–150 p.
3. IDAI. Konsesus nasional pengelolaan diabetes melitus tipe 1 [Internet]. 2015. 6–36 p. Available from: http://www.idai.or.id/wp-content/uploads/2016/06/Konsensus Endokrin DM tipe 1 (2015).pdf
4. Skalli S, Hassikou R, Arahou M. An ethnobotanical survey of medicinal plants used for diabetes treatment in Rabat, Morocco. Heliyon. 2019;(September 2018): e01421.
5. Rachkeeree A, Kantadoung K, Suksathan R, Puangpradab R, Page PA, Sommano SR. Nutritional compositions and phytochemical properties of the edible flowers from selected zingiberaceae found in Thailand. 2018;5(February):1–10.
6. Rachkeeree A, Kantadoung K, Suksathan R, Puangpradab R, Page PA, Sommano SR. Nutritional Compositions and Phytochemical Properties of the Edible Flowers from Selected Zingiberaceae Found in Thailand. 2018;5(February):1–10.
7. Lianah. Biodiversitas Zingiberaceae: Mijen Kota Semarang. 2020.
8. Arumugam G, Manjula P, Paari N. A review: Anti diabetic medicinal plants used for diabetes mellitus. Journal of Acute Disease. 2013;2(3):196–200.
9. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods [Internet]. n/a(n/a). Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jrsm.1411
10. Aghasi M, Koohdani F, Qorbani M, Nasli-esfahani E, Ghazi-zahedi S, Khoshamal H. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial. 2019;(March).
11. Kitada M, Koya D. SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab J. 2013;37(5):315–25.
12. Rivera-Mancía S, Lozada-García MC, Pedraza-Chaverri J. Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications. Eur J Pharmacol. 2015 Jun 5; 756:30–7.
13. Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G. The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: A randomized, double-blind clinical trial. Diabetol Metab Syndr [Internet]. 2019;11(1):1–8. Available from: https://doi.org/10.1186/s13098-019-0437-7
14. Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M, et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res [Internet]. 2013 Sep [cited 2024 Dec 10];57(9):1569–77. Available from: https://pubmed.ncbi.nlm.nih.gov/22930403/
15. El Gayar MH, Aboromia MMM, Ibrahim NA, Abdel Hafiz MH. Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus. Obes Med. 2019 Jun 1; 14:100094.
16. Rani MP, Padmakumari KP, Sankarikutty B, Cherian OL, Nisha VM, Raghu KG. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Int J Food Sci Nutr. 2011;62(2):106–110.
17. Arzati MM, Honarvar NM, Saedisomeolia A, Anvari S, Effatpanah M, Arzati RM, et al. The effects of ginger on fasting blood sugar, hemoglobin A1c, and lipid profiles in patients with type 2 diabetes. Int J Endocrinol Metab. 2017;15(4):0–6.
18. Panahi Y, Khalili N, Sahebi E, Namazi S, Simental-Mendía LE, Majeed M, et al. Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Res. 2018;68(7):403–9.
19. Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial. Complement Ther Med [Internet]. 2019;43(August):253–60. Available from: https://doi.org/10.1016/j.ctim.2019.02.014
20. Shafabakhsh R, Asemi Z, Reiner Ž, Soleimani A, Aghadavod E, Bahmani F. The effects of nano-curcumin on metabolic status in patients with diabetes on hemodialysis, a randomized, double blind, placebo-controlled trial. Iran J Kidney Dis. 2020;14(4):290–9.
21. Mokhtari M, Razzaghi R, Momen-Heravi M. The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. Phytotherapy Research. 2021;35(4):2099–107.
22. Darmian MA, Hoseini R, Amiri E, Golshani S. How combined and separate aerobic training and turmeric supplementation alter lipid profile and glycemic status? A clinical trial in middle-aged females with type 2 diabetes and hyperlipidemia. Int Cardiovasc Res J. 2021;15(3):111–8.
23. Sousa DF De, Flávio M, Araújo M De, De VD, Maria M, Damasceno C, et al. Cost-effectiveness of passion fruit albedo versus turmeric in the glycemic and lipaemic control of people with type 2 diabetes: randomized clinical trial. J Am Coll Nutr [Internet]. 2021;40(8):679–88. Available from: https://doi.org/10.1080/07315724.2020.1823909
24. Joana N, Figueiredo F De, Saraiva VV, De SDF, Maria C, Maria Q, et al. Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial. Int J Food Sci Nutr [Internet]. 2021;0(0):1–10. Available from: https://doi.org/10.1080/09637486.2021.1885015
25. Panahi Y, Khalili N, Sahebi E, Namazi S, Atkin SL, Majeed M, et al. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology. 2017;25(1):25–31.
26. Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr [Internet]. 2011 Apr [cited 2024 Dec 10];50(3):151–61. Available from: https://pubmed.ncbi.nlm.nih.gov/21442412/
27. Panahi Y, Khalili N, Sahebi E, Namazi S, Atkin SL, Majeed M, et al. Curcuminoids plus piperine modulate adipokines in type 2 diabetes mellitus. Curr Clin Pharmacol. 2017;12(4):253–258.
28. Shafabakhsh R, Mobini M, Raygan F, Aghadavod E, Ostadmohammadi V, Amirani E, et al. Curcumin administration and the effects on psychological status and markers of inflammation and oxidative damage in patients with type 2 diabetes and coronary heart disease. Clin Nutr ESPEN. 2020 Dec 1; 40:77–82.
29. Panahi Y, Khalili N, Sahebi E, Namazi S, Atkin SL, Majeed M, et al. Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial. Complement Ther Med. 2017 Aug 1; 33:1–5.
30. Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Phytother Res. 2019;33(5):1374–1383.
31. Adab Z, Eghtesadi S, Vafa MR, Heydari I, Shojaii A, Haqqani H, et al. Effect of turmeric on glycemic status, lipid profile, hs-CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytotherapy Research. 2019;33(4):1173–81.
32. Srinivasan A, Selvarajan S, Kamalanathan S, Kadhiravan T, Lakshmi NCP, Adithan S. Effect of Curcuma longa on vascular function in native Tamilians with type 2 diabetes mellitus: A randomized, double-blind, parallel arm, placebo-controlled trial. Phytother Res. 2019;33(7):1898–1911.
33. Vanaie A, Shahidi S, Iraj B, Siadat ZD, Kabirzade M, Shakiba F, et al. Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy. Journal of Research in Medical Sciences. 2019;24(1).
34. Asadi S, Gholami MS, Siassi F, Qorbani M, Sotoudeh G. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research. 2020;34(4):896–903.
35. Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Kakeya H, et al. Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus. J Diabetes Res. 2019;2019.
36. Gholinezhad H, Bazyar H, Rashidi H, Salehi P, Haghighi-zadeh MH, Zare Javid A. Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial. J Herb Med. 2020 Apr 1; 20:100315.
37. Hajimoosayi F, Sadatmahalleh SJ, Kazemnejad A, Pirjani R. Effect of ginger on the blood glucose level of women with gestational diabetes mellitus (GDM) with impaired glucose tolerance test (GTT): a randomized double- blind placebo-controlled trial. 2020; 5:1–7.
38. Carvalho GCN, Lira-Neto JCG, de Araújo MFM, de Freitas RWJF. Effectiveness of ginger in reducing metabolic levels in people with diabetes: a randomized clinical trial *. 2020;
39. Foroutan M, Yarmohamadi M, Ghorbani R, Movahhed H. The effect of ginger on blood sugar and urine protein in patients with type 2 diabetes mellitus; a clinical trial. 2021;10(x).
40. Talaei B, Mozaffari-khosravi H, Bahreini S. The effect of ginger on blood lipid and lipoproteins in patients with type 2 diabetes: a double-blind randomized clinical controlled trial. 2017;2(1):87–95.
41. Mozaffari-Khosravi H, Talaei B, Jalali BA, Najarzadeh A, Mozayan MR. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Complement Ther Med. 2014 Feb 1;22(1):9–16.
42. Carvalho GCN, Neto JCGL, Nunes LCC, Alencar AMPG, Marques RLL, Damasceno MM. Effectiveness of ginger in the treatment of type 2 diabetes mellitus: A pilot study of the randomized clinical trial type *. 2021; 21:1–14.
43. Honarvar MN, Zarezadeh M, Khorshidi M, Makhdoomi Arzati M, Yekaninejad MS, Abdollahi M, et al. The effect of an oral ginger supplementation on NF-κB concentration in peripheral blood mononuclear cells and anthropomorphic data of patients with type 2 diabetes: A randomized double-blind, placebo-controlled clinical trial. Complement Ther Med. 2019 Feb 1; 42:7–11.
44. Zarezadeh M, Saedisomeolia A, Khorshidi M, Kord Varkane H, Makhdoomi Arzati M, Abdollahi M, et al. Asymmetric dimethylarginine and soluble inter-cellular adhesion molecule-1 serum levels alteration following ginger supplementation in patients with type 2 diabetes: A randomized double-blind, placebo-controlled clinical trial. J Complement Integr Med. 2018;16(2).
45. Javid AZ, Bazyar H, Gholinezhad H, Rahimlou M, Rashidi H, Salehi P, et al. The effects of ginger supplementation on inflammatory, antioxidant, and periodontal parameters in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial. 2019;1751–61.
46. Badooei F, Imani E, Hosseini-Teshnizi S, Banar M, Memarzade MR. Comparison of the effect of ginger and aloe vera mouthwashes on xerostomia in patients with type 2 diabetes: A clinical trial, triple-blind. Med Oral Patol Oral Cir Bucal. 2021;26(4): e408–13.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sari Indah Kartika
This work is licensed under a Creative Commons Attribution 4.0 International License.
For submission of manuscripts to the Herb-Medicine Journal, the authors must certify that:
I have been authorized by my co-author to submit the manuscript to the Herb-Medicine Journal
I hereby declare, on behalf of myself and my co-authors, that:
The submitted manuscript is original work and has not been published in another peer-reviewed journal or is being considered for publication by another journal. Also, the manuscript does not infringe any existing copyright or other third party rights.
The manuscript does not contain material that may violate the law, slander, or SARA, in any way, violates the terms and conditions contained in the agreement
I/we have taken care that the scientific knowledge and all other statements contained in the manuscript are in accordance with authentic facts and formulas and will not, if followed appropriately, harm the user
No liability shall be assumed by Herb-Medicine Journal, its staff or members of the editorial board for any injury and/or damage to persons or property as a matter of product liability, negligence or otherwise, or from the use or operation of any method, product instructions, advertising , or ideas contained in publications by the Herb-Medicine Journal
Authors who publish in the Herb-Medicine Journal certify that all authors have read and agree to the contents of the Cover Letter or the Terms and Conditions. Plagiarism is strictly prohibited, and by submitting a manuscript for publication, the author agrees that the publisher has the legal right to take appropriate action against the author, if plagiarism or false information is found. Once submitted to the Herb-Medicine Journal, authors will not withdraw their manuscript at any stage prior to publication.
The author owns the copyright and grants the journal rights for first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows others to share the work with acknowledgment of the work's authorship and initial publication in this journal.
Authors may enter into separate additional contractual agreements for the non-exclusive distribution of the published journal version of the work (for example, posting it to an institutional repository or publishing it in a book), with acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their websites) prior to and during the submission process, as this can lead to productive exchanges, as well as earlier and larger citation of published work (See The Effects of Open Access).
Untuk pengiriman naskah ke Herb-Medicine Journal, penulis harus menyatakan bahwa:
- Saya telah diberikan otorisasi oleh rekan penulis saya untuk memasukkan naskah ke Herb-Medicine Journal
- Saya dengan ini menyatakan, atas nama saya dan rekan penulis saya, bahwa:
- Naskah yang dikirimkan adalah karya asli dan belum pernah diterbitkan dalam jurnal peer-review lain atau sedang dipertimbangkan untuk diterbitkan oleh jurnal lain. Serta, naskah tidak melanggar hak cipta yang ada atau hak pihak ketiga lainnya.
- Naskah tidak mengandung materi yang mungkin melanggar hukum, memfitnah, atau SARA, dengan cara apa pun, melanggar syarat dan ketentuan yang tercantum dalam perjanjian
- Saya / kami telah berhati-hati bahwa pengetahuan ilmiah dan semua pernyataan lain yang terkandung dalam naskah sesuai dengan fakta dan formula otentik dan tidak akan, jika diikuti dengan tepat, merugikan pengguna
- Tidak ada tanggung jawab yang ditanggung oleh Herb-Medicine Journal, stafnya atau anggota dewan editorial untuk setiap cedera dan/atau kerusakan pada orang atau properti sebagai masalah pertanggungjawaban produk, kelalaian atau sebaliknya, atau dari penggunaan atau pengoperasian metode, produk apa pun instruksi, iklan, atau ide yang terkandung dalam publikasi oleh Herb-Medicine Journal
Penulis yang menerbitkan dalam Herb-Medicine Journal menyatakan bahwa semua penulis telah membaca dan menyetujui isi Surat Pengantar atau Syarat dan Ketentuan. Plagiarisme dilarang keras, dan dengan menyerahkan naskah untuk publikasi, penulis setuju bahwa penerbit memiliki hak hukum untuk mengambil tindakan yang pantas terhadap penulis, jika ditemukan plagiarisme atau informasi palsu. Setelah diserahkan ke Herb-Medicine Journal, penulis tidak akan menarik naskah mereka pada tahap apa pun sebelum dipublikasikan.
Penulis memiliki hak cipta dan memberikan hak jurnal untuk publikasi pertama dengan karya yang secara simultan dilisensikan di bawah Lisensi Creative Commons Attribution yang memungkinkan orang lain untuk berbagi karya dengan pengakuan kepengarangan karya dan publikasi awal dalam jurnal ini.
Penulis dapat membuat perjanjian kontrak tambahan yang terpisah untuk distribusi non-eksklusif versi jurnal yang diterbitkan dari karya tersebut (misalnya, mempostingnya ke repositori institusional atau menerbitkannya dalam sebuah buku), dengan pengakuan atas publikasi awalnya di jurnal ini.
Penulis diizinkan dan didorong untuk memposting pekerjaan mereka secara online (misalnya, dalam repositori institusional atau di situs web mereka) sebelum dan selama proses pengajuan, karena dapat menyebabkan pertukaran yang produktif, serta kutipan yang lebih awal dan lebih besar dari karya yang diterbitkan (Lihat The Effect of Open Access).
